These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 31146625)
21. The Utility of Phosphohistone H3 (PHH3) in Follicular Lymphoma Grading: A Comparative Study With Ki-67 and H&E Mitotic Count. Khieu ML; Broadwater DR; Aden JK; Coviello JM; Lynch DT; Hall JM Am J Clin Pathol; 2019 May; 151(6):542-550. PubMed ID: 30788495 [TBL] [Abstract][Full Text] [Related]
22. Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas. Colman H; Giannini C; Huang L; Gonzalez J; Hess K; Bruner J; Fuller G; Langford L; Pelloski C; Aaron J; Burger P; Aldape K Am J Surg Pathol; 2006 May; 30(5):657-64. PubMed ID: 16699322 [TBL] [Abstract][Full Text] [Related]
23. Mitotic rate in melanoma: prognostic value of immunostaining and computer-assisted image analysis. Hale CS; Qian M; Ma MW; Scanlon P; Berman RS; Shapiro RL; Pavlick AC; Shao Y; Polsky D; Osman I; Darvishian F Am J Surg Pathol; 2013 Jun; 37(6):882-9. PubMed ID: 23629443 [TBL] [Abstract][Full Text] [Related]
24. Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas. Duregon E; Bertero L; Pittaro A; Soffietti R; Rudà R; Trevisan M; Papotti M; Ventura L; Senetta R; Cassoni P Oncotarget; 2016 Apr; 7(16):21190-8. PubMed ID: 27049832 [TBL] [Abstract][Full Text] [Related]
25. Potential Pitfalls in Diagnostic Digital Image Analysis: Experience with Ki-67 and PHH3 in Gastrointestinal Neuroendocrine Tumors. Hacking SM; Sajjan S; Lee L; Ziemba Y; Angert M; Yang Y; Jin C; Chavarria H; Kataria N; Jain S; Nasim M Pathol Res Pract; 2020 Mar; 216(3):152753. PubMed ID: 31761497 [TBL] [Abstract][Full Text] [Related]
26. The Impact of Phosphohistone-H3-Assisted Mitotic Count and Ki67 Score in the Determination of Tumor Grade and Prediction of Distant Metastasis in Well-Differentiated Pancreatic Neuroendocrine Tumors. Ozturk Sari S; Taskin OC; Gundogdu G; Yegen G; Onder S; Keskin M; Saglam S; Ozluk Y; Gulluoglu M; Mete O Endocr Pathol; 2016 Jun; 27(2):162-70. PubMed ID: 26936845 [TBL] [Abstract][Full Text] [Related]
27. Detection of mitotic figures in thin melanomas--immunohistochemistry does not replace the careful search for mitotic figures in hematoxylin-eosin stain. Ottmann K; Tronnier M; Mitteldorf C J Am Acad Dermatol; 2015 Oct; 73(4):637-44. PubMed ID: 26278815 [TBL] [Abstract][Full Text] [Related]
28. Mitotic Index Determined by Phosphohistone H3 Immunohistochemistry for Precise Grading in Follicular Lymphoma. Bedekovics J; Irsai G; Hegyi K; Beke L; Krenács L; Gergely L; Méhes G Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):579-585. PubMed ID: 27997502 [TBL] [Abstract][Full Text] [Related]
29. Phosphohistone-H3 (PHH3) is prognostic relevant in Merkel cell carcinomas but Merkel cell polyomavirus is a more powerful prognostic factor than AJCC clinical stage, PHH3, Ki-67 or mitotic indices. Iwasaki T; Matsushita M; Nonaka D; Kato M; Nagata K; Murakami I; Hayashi K Pathol Int; 2015 Aug; 65(8):404-9. PubMed ID: 25982855 [TBL] [Abstract][Full Text] [Related]
30. Does mitosis-specific marker phosphohistone H3 help the grading of upper tract urothelial carcinomas in cell blocks? Solomides CC; Birbe RC; Nicolaou N; Bagley D; Bibbo M Acta Cytol; 2012; 56(3):285-8. PubMed ID: 22555531 [TBL] [Abstract][Full Text] [Related]
31. Grading and Prognostication of Neuroendocrine Tumors of the Pancreas: A Comparison Study of Ki67 and PHH3. Tracht J; Zhang K; Peker D J Histochem Cytochem; 2017 Jul; 65(7):399-405. PubMed ID: 28651471 [TBL] [Abstract][Full Text] [Related]
32. Prognostic importance of the mitotic marker phosphohistone H3 in cutaneous nodular melanoma. Ladstein RG; Bachmann IM; Straume O; Akslen LA J Invest Dermatol; 2012 Apr; 132(4):1247-52. PubMed ID: 22297638 [TBL] [Abstract][Full Text] [Related]
33. Assessment of tumour proliferation by use of the mitotic activity index, and Ki67 and phosphohistone H3 expression, in early-stage luminal breast cancer. van Steenhoven JEC; Kuijer A; Kornegoor R; van Leeuwen G; van Gorp J; van Dalen T; van Diest PJ Histopathology; 2020 Oct; 77(4):579-587. PubMed ID: 32557844 [TBL] [Abstract][Full Text] [Related]
34. The potential value of phosphohistone-h3 mitotic index determined by digital image analysis in the assessment of pancreatic endocrine tumors in fine-needle aspiration cytology specimens. Draganova-Tacheva R; Bibbo M; Birbe R; Daskalakis C; Solomides C Acta Cytol; 2013; 57(3):291-5. PubMed ID: 23635399 [TBL] [Abstract][Full Text] [Related]
35. Ki67 index and mitotic count: Correlation and variables affecting the accuracy of the quantification in endocrine/neuroendocrine tumors. Huang W; Nebiolo C; Esbona K; Hu R; Lloyd R Ann Diagn Pathol; 2020 Oct; 48():151586. PubMed ID: 32836178 [TBL] [Abstract][Full Text] [Related]
36. The mitosis-specific antibody anti-phosphohistone-H3 (PHH3) facilitates rapid reliable grading of meningiomas according to WHO 2000 criteria. Ribalta T; McCutcheon IE; Aldape KD; Bruner JM; Fuller GN Am J Surg Pathol; 2004 Nov; 28(11):1532-6. PubMed ID: 15489659 [TBL] [Abstract][Full Text] [Related]
37. Identification of Phosphohistone H3 Cutoff Values Corresponding to Original WHO Grades but Distinguishable in Well-Differentiated Gastrointestinal Neuroendocrine Tumors. Kim MJ; Kwon MJ; Kang HS; Choi KC; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Choe JY; Park HC Biomed Res Int; 2018; 2018():1013640. PubMed ID: 29780816 [TBL] [Abstract][Full Text] [Related]
38. Mitotic Figures-Normal, Atypical, and Imposters: A Guide to Identification. Donovan TA; Moore FM; Bertram CA; Luong R; Bolfa P; Klopfleisch R; Tvedten H; Salas EN; Whitley DB; Aubreville M; Meuten DJ Vet Pathol; 2021 Mar; 58(2):243-257. PubMed ID: 33371818 [TBL] [Abstract][Full Text] [Related]
39. Mitosis count and number of cancer cells in cases of primary pulmonary adenocarcinoma: Correlations among phosphorylated histone 3, number of cancer cells, nuclear grade, pathologic features and prognosis. Inoue T; Nakazato Y; Karube Y; Maeda S; Kobayashi S; Chida M Pathol Int; 2018 Mar; 68(3):159-166. PubMed ID: 29393583 [TBL] [Abstract][Full Text] [Related]
40. Mitosin and pHH3 predict poorer survival in astrocytomas WHO grades II and III. Varughese RK; Lind-Landström T; Habberstad AH; Salvesen Ø; Haug CS; Sundstrøm S; Torp SH J Clin Pathol; 2016 Jan; 69(1):26-34. PubMed ID: 26188054 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]